Meghan Hattarki

1.4k citations

26 papers · 788 indexed · h-index 17

Co-authors: Stewart D. Nuttall Peter J. Hudson Robert A. Irving Larissa Doughty Olan Dolezal Davide Gori Jennifer A. Carmichael Alexander A. Kortt
Topics: Monoclonal and Polyclonal Antibodies Research (12 papers)Glycosylation and Glycoproteins Research (5 papers)Biochemical and Molecular Research (5 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Molecular Biology Immunology
Journals: PLoS ONE Analytical Biochemistry Journal of Medicinal Chemistry
Partner nations: Australia United Kingdom China

In The Last Decade

Meghan Hattarki

26 papers receiving 756 citations

Peers

Countries citing papers authored by Meghan Hattarki

Since Specialization

Citations

This map shows the geographic impact of Meghan Hattarki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan Hattarki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan Hattarki more than expected).

Fields of papers citing papers by Meghan Hattarki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan Hattarki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan Hattarki. The network helps show where Meghan Hattarki may publish in the future.

Co-authorship network of co-authors of Meghan Hattarki

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan Hattarki. A scholar is included among the top collaborators of Meghan Hattarki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan Hattarki. Meghan Hattarki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Crystal structures of human ENPP1 in apo and bound forms 2020 ·Acta Crystallographica Section D Structural Biology ·Matthew L. Dennis,Janet Newman,Olan Dolezal,Meghan Hattarki,Regina Surjadi,Stewart D. Nuttall,Tam Pham,Thomas Nebl,(unknown),(unknown),Brendon J. Monahan,Thomas S. Peat	26
2	Structure-Based Design and Development of Functionalized Mercaptoguanine Derivatives as Inhibitors of the Folate Biosynthesis Pathway Enzyme 6-Hydroxymethyl-7,8-dihydropterin Pyrophosphokinase from Staphylococcus aureus 2014 ·Journal of Medicinal Chemistry ·Matthew L. Dennis,Sandeep Chhabra,Zhong‐Chang Wang,Aaron DeBono,Olan Dolezal,Janet Newman,(unknown),Raphaël Rahmani,(unknown),Νicholas Barlow,Meghan Hattarki,Bim Graham,Thomas S. Peat,Jonathan B. Baell,James Swarbrick	13
3	Fragment Screening for the Modelling Community: SPR, ITC, and Crystallography 2013 ·Australian Journal of Chemistry ·Olan Dolezal,Larissa Doughty,Meghan Hattarki,Vincent Fazio,Tom T. Caradoc-Davies,Janet Newman,Thomas S. Peat	6
4	Fragment Screening on Staphylococcus aureus HPPK – a Folate Pathway Target 2013 ·Australian Journal of Chemistry ·Sandeep Chhabra,Olan Dolezal,Meghan Hattarki,Thomas S. Peat,Jamie S. Simpson,James Swarbrick	4
5	Central amyloid- -specific single chain variable fragment ameliorates A aggregation and neurotoxicity 2013 ·Protein Engineering Design and Selection ·Rebecca M. Nisbet,Julie Nigro,Kerry Breheney,Joanne M. Caine,Meghan Hattarki,Stewart D. Nuttall	16
6	Exploring the Chemical Space around 8-Mercaptoguanine as a Route to New Inhibitors of the Folate Biosynthesis Enzyme HPPK 2013 ·PLoS ONE ·Sandeep Chhabra,Νicholas Barlow,Olan Dolezal,Meghan Hattarki,Janet Newman,Thomas S. Peat,Bim Graham,James Swarbrick	15
7	An Efficient High-Throughput Screening Method for MYST Family Acetyltransferases, a New Class of Epigenetic Drug Targets 2011 ·SLAS DISCOVERY ·Hendrik Falk,(unknown),Hong Yang,(unknown),(unknown),George Nikolakopoulos,Regina Surjadi,John D. Bentley,Meghan Hattarki,Olan Dolezal,James M. Murphy,Brendon J. Monahan,Thomas S. Peat,Tim Thomas,Jonathan B. Baell,John P. Parisot,Ian P. Street	35
8	Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers 2008 ·Protein Engineering Design and Selection ·R. Robert,Olan Dolezal,Lynne J. Waddington,Meghan Hattarki,Roberto Cappai,Colin L. Masters,Peter J. Hudson,(unknown)	42
9	Kinetic screening of antibody–Im7 conjugates by capture on a colicin E7 DNase domain using optical biosensors 2008 ·Analytical Biochemistry ·Ralf J. Hosse,(unknown),Meghan Hattarki,(unknown),Lesley A. Pearce,Stewart D. Nuttall,Olan Dolezal	19
10	Dimerisation strategies for shark IgNAR single domain antibody fragments 2006 ·Journal of Immunological Methods ·(unknown),(unknown),(unknown),(unknown),Victor A. Streltsov,Larissa Doughty,Meghan Hattarki,Stewart D. Nuttall	39
11	Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffold 2006 ·Protein Engineering Design and Selection ·(unknown),Terrence D. Mulhern,Peter J. Hudson,Meghan Hattarki,Jennifer A. Carmichael,Stewart D. Nuttall	16
12	Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1 2004 ·Proteins Structure Function and Bioinformatics ·Stewart D. Nuttall,(unknown),(unknown),Jennifer A. Carmichael,Larissa Doughty,Meghan Hattarki,Andrew M. Coley,Joanne L. Casey,Robin F. Anders,Michael Foley,Robert A. Irving,Peter J. Hudson	88
13	Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies 2004 ·Cancer Immunology Immunotherapy ·Pamela J. Russell,Dean R. Hewish,(unknown),Katy Sterling-Levis,Kim Ow,Meghan Hattarki,Larissa Doughty,(unknown),(unknown),Peter L. Molloy,Jerome A. Werkmeister,Alexander A. Kortt	74
14	Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody 2004 ·Cancer Immunology Immunotherapy ·(unknown),Katy Sterling-Levis,Kim Ow,Larissa Doughty,Meghan Hattarki,(unknown),Dean R. Hewish,Alexander A. Kortt,Pamela J. Russell	18
15	Single-chain Fv multimers of the anti-neuraminidase antibody NC10: the residue at position 15 in the VL domain of the scFv-0 (VL−VH) molecule is primarily responsible for formation of a tetramer–trimer equilibrium 2003 ·Protein Engineering Design and Selection ·Olan Dolezal,Davide Gori,Mark Walter,Larissa Doughty,Meghan Hattarki,Peter J. Hudson,Alexander A. Kortt	29
16	Isolation and characterization of an IgNAR variable domain specific for the human mitochondrial translocase receptor Tom70 2003 ·European Journal of Biochemistry ·Stewart D. Nuttall,(unknown),Larissa Doughty,(unknown),Michael T. Ryan,Nicholas J. Hoogenraad,Meghan Hattarki,Jennifer A. Carmichael,Robert A. Irving,Peter J. Hudson	59
17	Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector 2001 ·Cancer Immunology Immunotherapy ·Barbara Power,Joanne M. Caine,(unknown),(unknown),Meghan Hattarki,(unknown),(unknown),Fiona E. Smyth,Andrew M. Scott,Alexander A. Kortt,Peter J. Hudson	26
18	Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries 2001 ·Molecular Immunology ·Stewart D. Nuttall,(unknown),Meghan Hattarki,Davide Gori,Robert A. Irving,Peter J. Hudson	122
19	Inactivation and Clearance of Viruses During the Manufacture of High Purity Factor IX 2000 ·Biologicals ·Anna Johnston,A. MacGregor,(unknown),Meghan Hattarki,(unknown),David A. Anderson,Neil H. Goss,(unknown),Eric Uren	19
20	Chromatographic removal and heat inactivation of hepatitis A virus during manufacture of human albumin 1998 ·Biotechnology and Applied Biochemistry ·(unknown),A. MacGregor,(unknown),Meghan Hattarki,David A. Anderson,Neil H. Goss	31

About Meghan Hattarki

Meghan Hattarki is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Infectious Diseases, having authored 26 papers that have together received 788 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (5 papers) and Biochemical and Molecular Research (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (378 citations), Molecular Biology (500 citations) and Immunology (131 citations). Meghan Hattarki has collaborated with scholars based in Australia, United Kingdom and China. Frequent co-authors include Stewart D. Nuttall, Peter J. Hudson, Robert A. Irving, Larissa Doughty, Olan Dolezal, Davide Gori, Jennifer A. Carmichael, Alexander A. Kortt, Thomas S. Peat and David A. Anderson. Their work appears in journals such as PLoS ONE, Analytical Biochemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact